Market Overview

PPD Expands Central Labs' Preclarus® Technology, Helping Clients Accelerate and Enhance Clinical Research Decision-Making

Share:

Pharmaceutical Product Development, LLC (PPD)
has expanded its central
lab
technology capabilities integrated with Preclarus®,
the comprehensive data solution that consolidates and standardizes
multisource data to give clients transparent, real-time access to
clinical trial operations, as well as patient and lab data. Features
include a new client portal, functionality improvements for the Preclarus
investigator site portal
and a new companion mobile app for the
investigator portal.

"The expansion of our central lab capabilities will improve the user
experience for our clients and investigative sites," said Christopher
Fikry, M.D., executive vice president of PPD® Laboratories.
"The innovations that Preclarus and our technology platform offer are
integral to supporting our clients' success by facilitating faster, more
informed decision-making about their compounds. At the same time, we are
continually expanding and enhancing our technology competencies to
better support the study needs of our investigator sites."

The features of the new client portal include visibility to real-time,
studywide data and specimen information; a customizable dashboard for
displaying key study metrics and tracking progress; complete sample
history and chain-of-custody reports; and a variety of related tools,
reports and capabilities.

The Preclarus investigator site portal enhancements include a variety of
new functionalities for logistics support and chain of custody, sample
storage, informed consent and reporting.

The new companion mobile app for the investigator site portal provides
connectivity with iOS and Android devices that can be downloaded from
the Apple App Store or Google Play, respectively; full integration of
data with the web-based version in real time; and secure access to alert
review and query resolution, subject registration and additional
functionalities.

PPD
Laboratories
was recognized
as a 2018 top innovator in drug development
by CenterWatch, a
leading publisher of clinical trials information for clinical research
professionals, for the Preclarus investigator site portal and the
companion mobile app, which was then still under development.

As a fully integrated component of PPD, a leading global contract
research organization, PPD Laboratories offers the most comprehensive
set of laboratory services in the industry, spanning bioanalytical,
biomarkers, central lab, GMP and vaccine sciences.

PPD Laboratories' central lab provides high-quality testing, results and
data across a wide range of technologies and applications for all phases
of pharmaceutical development. With standardized instrumentation,
calibrators and reporting mechanisms, the company's central lab
locations in Asia (Singapore and Shanghai, China), Europe (Brussels,
Belgium) and North America (Highland Heights, Kentucky) support clients
around the world.

About PPD

PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and lifecycle
management services. Our clients and partners include pharmaceutical,
biotechnology, medical device, academic and government organizations.
With offices in 47 countries and approximately 20,000 professionals
worldwide, PPD applies innovative technologies, therapeutic expertise
and a firm commitment to quality to help clients and partners bend the
cost and time curve of drug development and optimize value in delivering
life-changing therapies to improve health. For more information, visit www.ppdi.com.

View Comments and Join the Discussion!